APA Zitierstil

Johnson, D. B., Flaherty, K. T., Weber, J. S., Infante, J. R., Kim, K. B., Kefford, R. F., . . . Gonzalez, R. (2014). Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAF(V600)-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor. J Clin Oncol.

Chicago Zitierstil

Johnson, Douglas B., et al. "Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAF(V600)-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor." J Clin Oncol 2014.

MLA Zitierstil

Johnson, Douglas B., et al. "Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAF(V600)-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor." J Clin Oncol 2014.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.